Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|April 17, 2016
The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosisS Segawa, D Goto, A Iizuka, et al.
Cytotherapy|July 9, 2008
Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cellsO Imataki, Y Heike, H Makiyama, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 10, 1999
Effects of Sho-seiryu-to on experimental allergic rhinitis in guinea pigsM Sakaguchi, A Mase, Y Ikeda, et al.
Pharmacological Research|June 8, 2001
Protective effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbitsF Yoshie, A Iizuka, M Kubo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 16, 1998
Further pharmacological study on Sho-seiryu-to as an antiallergicM Sakaguchi, A Mase, A Iizuka, et al.
Journal of Atherosclerosis and Thrombosis|June 29, 2000
Antioxidative effects of Choi-oki-to and its ability to inhibit the progression of atheroma in KHC rabbitsA Iizuka, O T Iijima, K Kondo, et al.
Journal of Ethnopharmacology|February 25, 1999
Inhibitory effects of Dai-saiko-to (Da-Chai-Hu-Tang) on the progression of atherosclerotic lesions in Kurosawa and Kusanagi-hypercholesterolemic rabbitsA Iizuka, O T Iijima, F Yoshie, et al.
The American Journal of Chinese Medicine|November 4, 1998
Anti-inflammatory effects of mao-bushi-saishin-to in mice and ratsY Ikeda, O T Iijima, A Iizuka, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 7, 2001
General pharmacological properties of Sho-seiryu-to (TJ-19) extractsS Amagaya, A Iizuka, B Makino, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|February 1, 1985
[Combination chemotherapy with cis-dichlorodiammineplatinum (11) (CDDP) and bleomycin BLM in advanced esophageal carcinoma]M Hayakawa, K Morise, A Iizuka, et al.
Pageof 4